NO983860D0 - Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler - Google Patents

Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler

Info

Publication number
NO983860D0
NO983860D0 NO983860A NO983860A NO983860D0 NO 983860 D0 NO983860 D0 NO 983860D0 NO 983860 A NO983860 A NO 983860A NO 983860 A NO983860 A NO 983860A NO 983860 D0 NO983860 D0 NO 983860D0
Authority
NO
Norway
Prior art keywords
optionally substituted
alkyl
alkenyl
alkynyl
cycloalkyl
Prior art date
Application number
NO983860A
Other languages
English (en)
Other versions
NO983860L (no
Inventor
Fner-M Hl Ulrike K
Werner Kummer
Gerald Pohl
Wolfram Gaida
Erich Lehr
Joachim Mierau
Thomas Weiser
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002242097A external-priority patent/CA2242097C/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO983860D0 publication Critical patent/NO983860D0/no
Publication of NO983860L publication Critical patent/NO983860L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
NO983860A 1996-07-20 1998-08-21 Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler NO983860L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629378A DE19629378A1 (de) 1996-07-20 1996-07-20 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1997/003841 WO1998003511A1 (de) 1996-07-20 1997-07-17 Neue triazolopurine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA002242097A CA2242097C (en) 1996-07-20 1998-06-26 Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO983860D0 true NO983860D0 (no) 1998-08-21
NO983860L NO983860L (no) 1998-10-21

Family

ID=32963000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983860A NO983860L (no) 1996-07-20 1998-08-21 Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler

Country Status (25)

Country Link
EP (2) EP0880524B1 (no)
JP (1) JP3020281B2 (no)
CN (1) CN1219936A (no)
AT (1) ATE191913T1 (no)
AU (1) AU3695597A (no)
BG (1) BG102707A (no)
BR (1) BR9710747A (no)
CA (1) CA2256736A1 (no)
CZ (1) CZ265498A3 (no)
DE (2) DE19629378A1 (no)
DK (1) DK0880524T3 (no)
EE (1) EE9800451A (no)
ES (1) ES2147453T3 (no)
GR (1) GR3033842T3 (no)
HR (1) HRP970395A2 (no)
HU (1) HUP9902311A3 (no)
ID (1) ID19106A (no)
IL (1) IL126453A0 (no)
NO (1) NO983860L (no)
PL (1) PL328824A1 (no)
PT (1) PT880524E (no)
SK (1) SK114498A3 (no)
TR (1) TR199801659T2 (no)
WO (1) WO1998003511A1 (no)
ZA (1) ZA976331B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826843A1 (de) * 1998-06-16 1999-12-23 Boehringer Ingelheim Pharma Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6492377B1 (en) 1998-06-25 2002-12-10 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines with adenosine-antagonistic activity
AU9347498A (en) * 1998-08-27 2000-03-21 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines
US7329668B2 (en) 2003-02-25 2008-02-12 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
EP2044074A2 (en) * 2006-06-23 2009-04-08 Incyte Corporation Purinone derivatives as hm74a agonists
CN112384515A (zh) 2018-02-27 2021-02-19 因赛特公司 作为a2a/a2b抑制剂的咪唑并嘧啶和三唑并嘧啶
MX2020012376A (es) 2018-05-18 2021-03-09 Incyte Corp Derivados de pirimidina fusionados como inhibidores de los receptores de adenosina a2a/a2b.
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
CN112778311A (zh) * 2019-11-01 2021-05-11 上海翰森生物医药科技有限公司 含氮并环类衍生物抑制剂、其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623755B2 (en) * 1989-03-29 1992-05-21 Merrell Pharmaceuticals Inc. Selective adenosine receptor compounds
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
JPH083169A (ja) * 1994-06-15 1996-01-09 Yamasa Shoyu Co Ltd ４−メチル−１Ｈ−［１，２，４］トリアゾロ［１，５−ａ］プリン−９（４Ｈ）−オン類

Also Published As

Publication number Publication date
BR9710747A (pt) 1999-08-17
WO1998003511A1 (de) 1998-01-29
ZA976331B (en) 1999-01-25
AU3695597A (en) 1998-02-10
SK114498A3 (en) 1999-02-11
ID19106A (id) 1998-06-18
EP0880524A1 (de) 1998-12-02
DK0880524T3 (da) 2000-07-17
PL328824A1 (en) 1999-02-15
GR3033842T3 (en) 2000-10-31
HRP970395A2 (en) 1998-08-31
CN1219936A (zh) 1999-06-16
NO983860L (no) 1998-10-21
EP0978517A2 (de) 2000-02-09
BG102707A (en) 1999-09-30
TR199801659T2 (xx) 1998-12-21
IL126453A0 (en) 1999-08-17
CA2256736A1 (en) 1998-01-29
JP2000501420A (ja) 2000-02-08
EE9800451A (et) 1999-06-15
DE19629378A1 (de) 1998-01-29
CZ265498A3 (cs) 1998-12-16
EP0978517A3 (de) 2003-11-12
HUP9902311A2 (hu) 1999-10-28
JP3020281B2 (ja) 2000-03-15
ATE191913T1 (de) 2000-05-15
PT880524E (pt) 2000-07-31
ES2147453T3 (es) 2000-09-01
DE59701467D1 (de) 2000-05-25
HUP9902311A3 (en) 2000-06-28
EP0880524B1 (de) 2000-04-19

Similar Documents

Publication Publication Date Title
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
FI953089A0 (fi) Boorihaposta johdetut uudet peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
NO305365B1 (no) Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter
NO20051754D0 (no) Quinolylpropylpiperidinderivater, fremgangsmate for fremstilling derav og mellomprodukter og preparater inneholdende slike derivater
DK0708101T3 (da) Nye piperidinderivater, der er anvendelige som neurokinin-receptorantagonister
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
HK1071892A1 (en) New camptothecin analogue compounds, a process fortheir preparation and pharmaceutical compositions containing them
NO994947L (no) Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
HU0000308D0 (en) New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them
NO981814L (no) Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger som inneholder dem
NO975402D0 (no) Nye benzopyran forbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem
HUP9903968A2 (hu) Nem-peptid bombezin receptor antagonisták és alkalmazásuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application